Actively managed ETF that invests in companies that focus on gene editing, genetic therapy and stem cell advances. 1 year return of 130%+ in 2020.
Not going to happen. Use the search function to find out why.
And welcome to the community.
what do you mean use the search function?
can you quickly explain why it’s not going to happen?
He means search the forum, unfortunately US ETFs aren’t available to EU investors, so you’ll have to look for an alternative like DRDR or IBT.
thanks Adam! Is this a regulation issue?